HENDERSON MORLEY RES & DEV LTD has a total of 37 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United Kingdom, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals and foods and drinks are MEDICE ARZNEIMITTEL PUETTER GMBH & CO KG, HMFRA HUNGARY LTD LIABILITY COMPANY and RELIANT PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 13 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Australia | 4 | |
#4 | United States | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | China | 2 | |
#7 | Argentina | 1 | |
#8 | Brazil | 1 | |
#9 | Canada | 1 | |
#10 | Israel | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Hartley Christopher Edward | 18 |
#2 | Pardoe Ian Stuart | 8 |
#3 | Hartley Christopher E | 3 |
#4 | Pardoe Ian S | 2 |
#5 | Hartley Christopher | 1 |
#6 | Hartley Christoper Edward | 1 |
#7 | Pardo Ian | 1 |
Publication | Filing date | Title |
---|---|---|
US2006122174A1 | Antiviral treatment | |
WO0224207A1 | Diuretic or sulphonylurea for use in antiviral treatment | |
GB0116818D0 | DNA viral infections | |
GB0114947D0 | Treatment of DNA viral infections in cats | |
GB0104030D0 | Antiviral treatment | |
GB0104031D0 | Antiviral treatment | |
EP1242096A2 | Pharmaceutucal compositions for the treatment of dna viral infections comprising a loop diuretic and lithium | |
AU1873401A | Treatment of DNA viral infections | |
GB0023200D0 | Synergistic treatment of DNA viral infections | |
GB0023198D0 | Treatment of DNA viral infections | |
GB0023199D0 | Antiviral treatment | |
GB0005382D0 | Pharmaceutical composition | |
GB0000683D0 | Antiviral treatment | |
GB9924389D0 | Anti-viral treatment | |
GB9907596D0 | Antiviral composition |